Test Price
700 AED✅ Home Collection Available
CCHF (Crimean-Congo Hemorrhagic Fever) RNA Detection, Qualitative Test in UAE | 700 AED
Executive Summary & Core Metrics
- ✓Accuracy Guarantee: 99.9% Diagnostic Sensitivity via Real-Time PCR + WGS Confirmation, ISO 9001:2015 Accredited.
- ✓Premium Logistics: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility; mobile home phlebotomy is disabled for safety.
- ✓Clinical Guidance: Telephonic Post-Test Clinical Guidance by DHA-Licensed Physicians for result interpretation and next steps.
- ✓Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
This qualitative molecular assay definitively identifies Crimean-Congo Hemorrhagic Fever virus RNA, providing a laboratory-confirmed diagnosis critical for immediate isolation and supportive care in line with Federal Decree-Law No. 4 of 2016 on Medical Liability.
Test Overview & Methodology
The CCHF RNA Qualitative Test detects viral genetic material in whole blood, serum, plasma, or cerebrospinal fluid via Real-Time PCR (qPCR) with whole-genome sequencing confirmation. This molecular approach offers superior sensitivity during the early viremic phase compared to serological methods, making it the gold standard for early diagnosis and outbreak response.
| Feature | Our CCHF RNA Test | Serological IgM/IgG Test |
|---|---|---|
| Methodology | Real-Time PCR (qPCR) + WGS confirmation | ELISA / Immunofluorescence |
| Target | Viral RNA (direct pathogen detection) | Host antibodies (indirect immunity) |
| Window of Reliability | From day 1 of symptoms (viremic phase) | Seroconversion after 5-7 days; often false-negative early |
| Turnaround Time | 36 hours (telephone) / 48 hours (email) | 1-3 days |
| Clinical Utility | Early isolation, outbreak control, definitive diagnosis | Retrospective seroprevalence, convalescent confirmation |
Physician Insight & Safety Protocols
Lina Osama Zaki Quteineh | Consultant Medical Genetics | DHA Registration ID: 9294403
"This molecular assay is the cornerstone of early CCHF control. A negative result in the first 48 hours of fever does not entirely exclude infection, so repeat testing and clinical correlation remain essential. Positive RNA findings must be immediately reported to UAE health authorities per communicable disease regulations, while highly suspicious negative cases should be managed as potential infections until proven otherwise. Hospital extraction ensures the highest safety standards for handling potentially hazardous specimens."
Important Advisory
Do not discontinue prescribed medication without consulting your doctor. This test does not replace clinical evaluation. All procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability for patient safety and informed consent.
Exclusion Criteria & Emergency Red Flags
- Patients with active, uncontrolled bleeding (hematemesis, melena, severe epistaxis) requiring immediate emergency care.
- Hemodynamic instability (shock, altered consciousness) where phlebotomy delay could harm – proceed directly to hospital.
- Minors (<18 years) without guardian consent.
- Individuals unable to understand and sign the mandatory consent document.
- Seek emergency medical attention immediately if you develop sudden high fever (≥38.5°C), petechial rash, bleeding gums, severe headache, muscle pain, or confusion – these may indicate active CCHF.
Patient FAQ & Clinical Guidance
1. What is the CCHF RNA Qualitative Test and why is it critical for early diagnosis?
This Real-Time PCR test detects CCHF viral RNA within 36 hours, enabling rapid isolation and clinical management. It identifies viral genetic material in whole blood, serum, plasma, or cerebrospinal fluid, offering superior sensitivity compared to antibody tests during the early viremic phase. The test is essential for confirming Crimean-Congo hemorrhagic fever in suspected cases and initiating immediate public health measures.
2. How should I prepare for the CCHF test and what does the hospital collection process involve?
No fasting is required, but you must present any prior medical records related to hemorrhagic fever or travel to endemic areas. Collection is performed exclusively within an accredited hospital facility by trained medical staff using full personal protective equipment. The specimen is immediately dispatched to our ISO 9001:2015 laboratory under constant temperature monitoring via secure medical courier.
3. Are there any risks or exclusion criteria for this test?
Standard venipuncture risks are minimal but may be heightened in patients with coagulopathy or low platelet counts. A physician reviews your pre-test information to ensure safety before collection. Testing is not performed on individuals who are haemodynamically unstable or those without guardian consent for minors. If you experience sudden high fever, bleeding gums, or severe headache, seek emergency care immediately.
4. How do I schedule the test and what happens after results are available?
Contact us via WhatsApp at +971 54 548 8731 to schedule your hospital-based collection. Results are available within 36 hours via telephone or 48 hours via email. A DHA-licensed physician provides telephonic post-test clinical guidance for result interpretation. Any positive result triggers immediate notification to UAE health authorities per communicable disease regulations.
UAE Regulatory & Data Privacy Adherence
All patient data is protected per Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical procedures follow Federal Decree-Law No. 4 of 2016 on Medical Liability for patient safety and informed consent. Our laboratory operates under DHA/MOHAP Standard Nomenclature and ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | CCHF (Crimean-Congo Hemorrhagic Fever) RNA Detection, Qualitative Test |
| Price (AED) | 700 |
| Turnaround Time | 36 hours (telephone) / 48 hours (email) |
| Sample Type / Matrix | Whole Blood, Serum, Plasma, or Cerebrospinal Fluid (CSF) |
| Methodology Used | Real-Time PCR (qPCR) with Whole-Genome Sequencing (WGS) Confirmation |
| ICD-10-CM Code | A98.0 |
| LOINC Code | LP142397-0 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians